Korea Pharma Co Ltd banner
K

Korea Pharma Co Ltd
KOSDAQ:032300

Watchlist Manager
Korea Pharma Co Ltd
KOSDAQ:032300
Watchlist
Price: 12 040 KRW -1.15% Market Closed
Market Cap: ₩131.4B

Korea Pharma Co Ltd
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Korea Pharma Co Ltd
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
K
Korea Pharma Co Ltd
KOSDAQ:032300
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Stock-Based Compensation
₩549m
CAGR 3-Years
17%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Stock-Based Compensation
₩3.6B
CAGR 3-Years
291%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Korea Pharma Co Ltd
Glance View

Market Cap
131.4B KRW
Industry
Pharmaceuticals

KOREA PHARMA Co., Ltd. is engaged in the manufacturing of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2020-08-10. The firm's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.

Intrinsic Value
12 407.71 KRW
Undervaluation 3%
Intrinsic Value
Price ₩12 040
K

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett